WEBVTT - Understanding Obesity and Alzheimer’s via Epigenomics

0:00:15.356 --> 0:00:28.996
<v Speaker 1>Pushkin. I'm Jacob Goldstein and this is What's Your Problem,

0:00:29.076 --> 0:00:31.196
<v Speaker 1>the show where I talk to people who are trying

0:00:31.236 --> 0:00:35.716
<v Speaker 1>to make technological progress. My guest today is Manola's. Kellis

0:00:36.196 --> 0:00:40.236
<v Speaker 1>Manola's is a professor of computer science at MIT, and

0:00:40.276 --> 0:00:44.956
<v Speaker 1>he works in computational biology. It's a field where researchers

0:00:44.996 --> 0:00:48.516
<v Speaker 1>take giant data sets relating to things like genetics and

0:00:48.636 --> 0:00:52.596
<v Speaker 1>health outcomes and try and understand basically what's going on,

0:00:52.916 --> 0:00:56.316
<v Speaker 1>things like what are the cellular mechanisms of disease and

0:00:56.476 --> 0:00:59.476
<v Speaker 1>how can we intervene to keep people healthy. In particular,

0:00:59.836 --> 0:01:04.836
<v Speaker 1>Minola's research focuses on genomics and a related field called epigenomics.

0:01:05.196 --> 0:01:07.236
<v Speaker 1>Here's how Manola's explains.

0:01:06.836 --> 0:01:13.276
<v Speaker 2>What that means. What's extraordinary with genomics is that we

0:01:13.356 --> 0:01:18.476
<v Speaker 2>can see beyond the limits of human imagination. We're talking

0:01:18.476 --> 0:01:21.916
<v Speaker 2>about millions of cells across hundreds of people, across thousands

0:01:21.916 --> 0:01:25.356
<v Speaker 2>of genes, and now we can now look at how

0:01:25.596 --> 0:01:29.916
<v Speaker 2>the single genome manifests in every cell type of the

0:01:29.996 --> 0:01:33.516
<v Speaker 2>human body in a slightly different way to create this

0:01:33.596 --> 0:01:38.836
<v Speaker 2>extraordinary symphony that is the human life, that is human thought,

0:01:38.876 --> 0:01:43.556
<v Speaker 2>that is human understanding, cognition, and every biological process that

0:01:44.236 --> 0:01:48.636
<v Speaker 2>ability to now start understanding the building blocks of how

0:01:48.996 --> 0:01:53.476
<v Speaker 2>this human genome manifests into all of these myriad of

0:01:53.516 --> 0:01:57.636
<v Speaker 2>cell types and their interactions and their combinations and their

0:01:57.676 --> 0:02:02.596
<v Speaker 2>coordination and their communication is what we can do for

0:02:02.636 --> 0:02:04.956
<v Speaker 2>the first time. They're also giving us the entry points

0:02:05.516 --> 0:02:10.116
<v Speaker 2>for understanding the basis of human variation, the basis of

0:02:10.156 --> 0:02:13.836
<v Speaker 2>human disease, and the basis for reversing human disease.

0:02:14.276 --> 0:02:17.116
<v Speaker 1>So that is the very big picture view of what

0:02:17.196 --> 0:02:20.436
<v Speaker 1>Manola's does. In our conversation, we got into a lot

0:02:20.476 --> 0:02:23.916
<v Speaker 1>more detail. For one thing, Manola's talked about his work

0:02:23.956 --> 0:02:28.196
<v Speaker 1>on obesity, and that work is based on epigenomics, which

0:02:28.276 --> 0:02:31.676
<v Speaker 1>is basically the way in which different genes are turned

0:02:31.836 --> 0:02:34.236
<v Speaker 1>on and off, and this turns out to be a

0:02:34.276 --> 0:02:37.396
<v Speaker 1>really big deal. Manola's and I also talked about his

0:02:37.556 --> 0:02:40.996
<v Speaker 1>work on Alzheimer's disease. In that part of the conversation,

0:02:41.356 --> 0:02:43.556
<v Speaker 1>he talked about how he and his colleagues are trying

0:02:43.596 --> 0:02:48.156
<v Speaker 1>to find these key biological pathways that contribute to lots

0:02:48.196 --> 0:02:50.676
<v Speaker 1>of different diseases, and how they're trying to come up

0:02:50.676 --> 0:02:55.036
<v Speaker 1>with drugs to target those pathways. We started our conversation

0:02:55.396 --> 0:02:58.516
<v Speaker 1>by talking about Manola's early work on the human genome,

0:02:58.676 --> 0:03:00.516
<v Speaker 1>which led to the work he's doing now.

0:03:00.636 --> 0:03:03.076
<v Speaker 2>So the human genome was mapped by K ninety nine

0:03:03.156 --> 0:03:05.396
<v Speaker 2>or two thousand and three, depending on how you count.

0:03:05.476 --> 0:03:08.196
<v Speaker 2>And then we had all of the nucleotides, all of

0:03:08.236 --> 0:03:13.676
<v Speaker 2>the letters through into billion letters. Then the hard part begins,

0:03:14.036 --> 0:03:15.796
<v Speaker 2>how do you make sense of that book? So that

0:03:15.876 --> 0:03:17.516
<v Speaker 2>was the Book of Life. So we had all of

0:03:17.516 --> 0:03:18.916
<v Speaker 2>the letters, how do you make sense of the book?

0:03:20.076 --> 0:03:26.596
<v Speaker 2>My own PhD was developing evolutionary signatures for understanding systematically

0:03:26.916 --> 0:03:30.676
<v Speaker 2>the human genome. So how do you recognize where are

0:03:30.716 --> 0:03:32.956
<v Speaker 2>the protein coding parts? What are the parts that code

0:03:32.956 --> 0:03:34.476
<v Speaker 2>for protein? We didn't even know.

0:03:34.676 --> 0:03:39.196
<v Speaker 1>And just to be clear, sort of non intuitively, most

0:03:39.236 --> 0:03:43.116
<v Speaker 1>of the human genome is not protein coding, right, Like

0:03:43.156 --> 0:03:46.676
<v Speaker 1>there's this very basic idea that like, oh, sure the genome,

0:03:46.676 --> 0:03:48.876
<v Speaker 1>that's what codes for proteins, but in fact, most of

0:03:48.916 --> 0:03:50.396
<v Speaker 1>the genome is not doing that.

0:03:51.196 --> 0:03:55.156
<v Speaker 2>Ninety eight percent of the human genome does not code

0:03:55.156 --> 0:03:55.676
<v Speaker 2>for protein.

0:03:55.796 --> 0:03:58.876
<v Speaker 1>It's wild. That is so nonintuitive, correct.

0:03:59.236 --> 0:04:02.916
<v Speaker 2>So in that mysterious ninety eight percent of the genome

0:04:03.396 --> 0:04:07.836
<v Speaker 2>lie control regents that are responsible for turning genes on

0:04:07.876 --> 0:04:13.756
<v Speaker 2>and off. And that's where ninety three percent of the

0:04:13.876 --> 0:04:16.556
<v Speaker 2>disease associated genetic variants are sitting.

0:04:17.156 --> 0:04:20.876
<v Speaker 1>Huh, it's not the genes that actually code for proteins,

0:04:20.956 --> 0:04:24.476
<v Speaker 1>it's the genes that control when are proteins made, when

0:04:24.476 --> 0:04:25.996
<v Speaker 1>are they not made, how much are they made.

0:04:26.076 --> 0:04:26.836
<v Speaker 2>That's exactly right.

0:04:26.916 --> 0:04:31.636
<v Speaker 1>Okay, so I get that in a broad sense. That's

0:04:31.676 --> 0:04:34.036
<v Speaker 1>sort of the state of affairs when you're coming into the.

0:04:34.036 --> 0:04:37.556
<v Speaker 2>Field's exactly right. So I wrote a series of papers,

0:04:37.636 --> 0:04:40.036
<v Speaker 2>both as a student and as a faculty member that

0:04:40.196 --> 0:04:44.276
<v Speaker 2>sought to then uncover how to even parse the genome,

0:04:44.316 --> 0:04:46.636
<v Speaker 2>how to even start understanding reading that book of life.

0:04:47.076 --> 0:04:49.796
<v Speaker 2>So that's one part. The second part is where the

0:04:49.836 --> 0:04:53.076
<v Speaker 2>regulatory motifs are. What are regulatory motifs. They are the

0:04:53.116 --> 0:04:57.556
<v Speaker 2>short words of the language of DNA that are bound

0:04:58.116 --> 0:05:02.196
<v Speaker 2>by regulators to turn genes on and off. So there's

0:05:02.236 --> 0:05:06.716
<v Speaker 2>these regulatory regions, and within these regions lie these words

0:05:07.676 --> 0:05:09.556
<v Speaker 2>which are the regulatory mode.

0:05:09.716 --> 0:05:13.756
<v Speaker 1>And just to be clear, the regulatory motifs are part

0:05:13.756 --> 0:05:17.396
<v Speaker 1>of what determine sort of when and how much different

0:05:17.436 --> 0:05:19.116
<v Speaker 1>genes express different proteins.

0:05:19.196 --> 0:05:21.636
<v Speaker 2>That's exactly right, that's exactly right. And that's where the

0:05:21.716 --> 0:05:24.476
<v Speaker 2>human epigenome comes in. So what we needed to now

0:05:24.556 --> 0:05:28.156
<v Speaker 2>understand is how that genome turns to life. So you

0:05:28.196 --> 0:05:30.756
<v Speaker 2>can think of the epigenome as the living genome, as

0:05:30.796 --> 0:05:33.836
<v Speaker 2>the genome. There's the genome itself is static. It's just

0:05:33.876 --> 0:05:36.316
<v Speaker 2>the book the tablets, if you wish that Moses brought

0:05:36.356 --> 0:05:40.076
<v Speaker 2>down from the mountain, and then the epigenome is the

0:05:40.276 --> 0:05:43.796
<v Speaker 2>music that gets played from the orchestra. The epigenome tells

0:05:43.836 --> 0:05:47.116
<v Speaker 2>you which parts are active in the brain and the liver,

0:05:47.236 --> 0:05:49.236
<v Speaker 2>and the heart and the muscle and so and so forth.

0:05:49.796 --> 0:05:53.156
<v Speaker 1>So your work on the epigenome is really interesting to me.

0:05:53.676 --> 0:05:56.356
<v Speaker 1>And I know you've done some work on obesity, and

0:05:56.396 --> 0:05:58.996
<v Speaker 1>the epigenome tell me about that.

0:05:59.436 --> 0:06:02.796
<v Speaker 2>The strongest genetic association with obesity sits in one gene

0:06:03.476 --> 0:06:09.676
<v Speaker 2>called FTO, and FTO was renamed fat and obesity associated

0:06:09.716 --> 0:06:13.716
<v Speaker 2>after that discovery, and it remained mysterious for seven years.

0:06:14.036 --> 0:06:16.436
<v Speaker 2>People had no idea how that gene works.

0:06:16.836 --> 0:06:17.876
<v Speaker 1>You just saw correlate.

0:06:17.956 --> 0:06:18.676
<v Speaker 2>There was a correlation.

0:06:18.836 --> 0:06:19.516
<v Speaker 1>There was a correlation.

0:06:19.836 --> 0:06:22.316
<v Speaker 2>Just the problem of genetics and the beauty of genetics.

0:06:22.356 --> 0:06:24.716
<v Speaker 2>The beauty of genetics is that it tells you what

0:06:24.996 --> 0:06:28.516
<v Speaker 2>region is responsible for disease. Regardless of how it functions.

0:06:29.156 --> 0:06:32.036
<v Speaker 2>The downside is that it after he tells.

0:06:31.756 --> 0:06:32.836
<v Speaker 1>You it's the same thing.

0:06:33.596 --> 0:06:36.076
<v Speaker 2>After it tells you that he has a role, you

0:06:36.116 --> 0:06:40.596
<v Speaker 2>have no idea how it functions. And what we showed

0:06:41.196 --> 0:06:45.956
<v Speaker 2>in our work is that that region doesn't affect the

0:06:46.076 --> 0:06:47.276
<v Speaker 2>FTO gene at all.

0:06:47.356 --> 0:06:50.556
<v Speaker 1>So like in the middle of a gene, there is

0:06:50.596 --> 0:06:56.316
<v Speaker 1>this whatever series of nucleotides, but those those nucleotides are

0:06:56.356 --> 0:06:58.396
<v Speaker 1>just randomly in the middle of that gene and actually

0:06:58.436 --> 0:07:00.156
<v Speaker 1>have nothing to do with that gene. I didn't even

0:07:00.156 --> 0:07:01.276
<v Speaker 1>know you could do that.

0:07:01.236 --> 0:07:07.156
<v Speaker 2>Fairly, you can't. So there are eighty nine differences, eighty

0:07:07.236 --> 0:07:11.876
<v Speaker 2>nine common variants, common genetic variants that are all coinherited.

0:07:12.236 --> 0:07:14.596
<v Speaker 2>If you get a here, you get all of the

0:07:14.636 --> 0:07:19.116
<v Speaker 2>other you know, actage, you get that passage. If you

0:07:19.116 --> 0:07:22.116
<v Speaker 2>get that package, it spans fifty thousand letters. But there

0:07:22.156 --> 0:07:25.956
<v Speaker 2>are only eighty nine differences in these fifty thousand letters. Wow,

0:07:26.396 --> 0:07:32.116
<v Speaker 2>and these will increase your body weight by one standard deviation,

0:07:33.676 --> 0:07:35.676
<v Speaker 2>which is like how much it's like nine pounds, Like

0:07:35.756 --> 0:07:38.636
<v Speaker 2>it's a lot, okay. So so basically what that does

0:07:39.196 --> 0:07:42.756
<v Speaker 2>is that it functions somehow to increase your risk for

0:07:42.756 --> 0:07:46.516
<v Speaker 2>a basits, it's like the strongest genetic association before. And

0:07:47.276 --> 0:07:50.356
<v Speaker 2>what we reason is, how could it be acting. It

0:07:50.396 --> 0:07:52.596
<v Speaker 2>could be acting in your brain to decide whether you

0:07:52.716 --> 0:07:55.116
<v Speaker 2>like sweets or salting. It could be acting your muscle

0:07:55.156 --> 0:07:57.196
<v Speaker 2>to make you more fit or less fit. It could

0:07:57.236 --> 0:08:00.916
<v Speaker 2>be asking in your digestives. So we basically said, okay,

0:08:00.996 --> 0:08:03.716
<v Speaker 2>well that's speculation. Let's look at the data. And we

0:08:03.796 --> 0:08:05.716
<v Speaker 2>looked at the data and we found that there was

0:08:05.796 --> 0:08:11.316
<v Speaker 2>this massive control region that was active in mesenchymal stem

0:08:11.356 --> 0:08:13.916
<v Speaker 2>cells what are mesimo cells and sells. They are the

0:08:13.956 --> 0:08:21.036
<v Speaker 2>progenitors of brown fat and white fat. Now, white fat

0:08:21.396 --> 0:08:24.836
<v Speaker 2>is white because it's full of lipids. That's where all

0:08:24.876 --> 0:08:28.276
<v Speaker 2>the calories are stored. Brown fat is brown because of

0:08:28.316 --> 0:08:31.076
<v Speaker 2>all of the iron in the mitochondria. That's where the

0:08:31.076 --> 0:08:34.156
<v Speaker 2>calories are burned. So it turns out that our fat

0:08:34.196 --> 0:08:38.076
<v Speaker 2>cells make a developmental decision in their first three days

0:08:38.076 --> 0:08:41.756
<v Speaker 2>of differentiation to go down the white path lineage or

0:08:41.916 --> 0:08:45.396
<v Speaker 2>the brown path lineage. And what the white fat does

0:08:45.636 --> 0:08:51.796
<v Speaker 2>is it stores energies and brown burns energies. So it

0:08:51.836 --> 0:08:55.156
<v Speaker 2>turns out that I'm actually homozygous risk for the store

0:08:55.196 --> 0:08:58.796
<v Speaker 2>calories position, which is the obesity risk.

0:08:58.996 --> 0:09:00.476
<v Speaker 1>So you have the obesity.

0:09:00.596 --> 0:09:03.036
<v Speaker 2>I have two copies of the obesity risk. My wife

0:09:03.076 --> 0:09:06.276
<v Speaker 2>has zero. I can tell you, you know, we look

0:09:06.356 --> 0:09:12.196
<v Speaker 2>very different. Fair So we basically realize that it sits

0:09:12.196 --> 0:09:16.036
<v Speaker 2>in the progenitor cells of white and brown flat and

0:09:16.116 --> 0:09:19.836
<v Speaker 2>then we could show that the true target was not

0:09:19.956 --> 0:09:23.676
<v Speaker 2>the ftogene at all. It was instead two other genes

0:09:23.716 --> 0:09:28.116
<v Speaker 2>that are sitting one point two million letters away from

0:09:28.116 --> 0:09:31.796
<v Speaker 2>this region and six hundred thousand letters away, and those

0:09:31.836 --> 0:09:37.756
<v Speaker 2>genes turned out to be master controllers of thermogenesis. They

0:09:37.796 --> 0:09:44.116
<v Speaker 2>are basically switching your metabolic state. So my cells are

0:09:44.236 --> 0:09:48.516
<v Speaker 2>stuck on the store position and my wife cells are

0:09:48.556 --> 0:09:49.716
<v Speaker 2>stuck on the burn position.

0:09:50.596 --> 0:09:53.676
<v Speaker 1>And so what is the relationship between the genes that

0:09:53.716 --> 0:09:59.116
<v Speaker 1>are acting here and this this you know, package variant

0:09:59.116 --> 0:10:00.636
<v Speaker 1>that is far away from them.

0:10:00.756 --> 0:10:05.196
<v Speaker 2>It comes back to the epigena. So our DNA is

0:10:05.316 --> 0:10:10.596
<v Speaker 2>stored inside a tiny little space. The way that gene

0:10:10.596 --> 0:10:13.476
<v Speaker 2>regulation works is that you have these control regions that

0:10:13.516 --> 0:10:17.716
<v Speaker 2>are scattered throughout the region of every gene that are

0:10:17.796 --> 0:10:21.076
<v Speaker 2>linked together to that gene in three dimensions. So they

0:10:21.156 --> 0:10:22.836
<v Speaker 2>do around and.

0:10:22.756 --> 0:10:24.796
<v Speaker 1>So it's it's far away. If you think of it

0:10:24.836 --> 0:10:27.636
<v Speaker 1>as a strand but in three dimensional space, right there,

0:10:27.996 --> 0:10:32.276
<v Speaker 1>three dimension pats right, Ah, that's satisfying.

0:10:32.396 --> 0:10:36.036
<v Speaker 2>And when we took these genes and we modulated them,

0:10:36.636 --> 0:10:41.436
<v Speaker 2>we show that you can turn off one gene in mouse,

0:10:42.276 --> 0:10:46.956
<v Speaker 2>in specifically the adipocytes of mouse with a dominant negative

0:10:46.996 --> 0:10:51.316
<v Speaker 2>cus of fat cells with a dominant negative construct, and

0:10:51.476 --> 0:10:56.236
<v Speaker 2>that turned the mouse fifty percent leaner. They eat the

0:10:56.276 --> 0:10:59.556
<v Speaker 2>same amount, they exercise the same amount, but they burn

0:10:59.636 --> 0:11:03.756
<v Speaker 2>calories when they're awake and they burn calories when they're sleeping.

0:11:05.036 --> 0:11:08.116
<v Speaker 2>And what's really fascinated with that story is that the

0:11:08.276 --> 0:11:13.116
<v Speaker 2>variant associated with obesity is at two percent frequency in Africa,

0:11:13.996 --> 0:11:17.716
<v Speaker 2>but forty two percent frequency in Europe and forty four

0:11:17.756 --> 0:11:22.276
<v Speaker 2>percent frequency in Southeast Asia. So it rose from two

0:11:22.316 --> 0:11:27.196
<v Speaker 2>percent to forty four percent maybe because of positive selection.

0:11:27.996 --> 0:11:31.076
<v Speaker 2>Maybe it was beneficial to be able to store every

0:11:31.116 --> 0:11:31.676
<v Speaker 2>kind of.

0:11:31.556 --> 0:11:34.276
<v Speaker 1>Places where food is, where you have food is scarce

0:11:34.316 --> 0:11:36.436
<v Speaker 1>in moments of famine, exactly.

0:11:36.036 --> 0:11:38.276
<v Speaker 2>In the out of Africa event, this may have been

0:11:38.276 --> 0:11:40.916
<v Speaker 2>selected for. Or in the you know, ice ages, it

0:11:40.956 --> 0:11:44.316
<v Speaker 2>may have been selected for. And it's only after World

0:11:44.316 --> 0:11:49.036
<v Speaker 2>War two that this variant became associated with obesity.

0:11:48.636 --> 0:11:51.036
<v Speaker 1>Because food became so abundant.

0:11:50.556 --> 0:11:54.436
<v Speaker 2>And we stopped exercising as much. So it's fascinating to

0:11:54.436 --> 0:11:58.196
<v Speaker 2>see how the environmental shift led to a new genetic

0:11:58.196 --> 0:12:02.956
<v Speaker 2>association which is now plaguing our society, and of course

0:12:02.996 --> 0:12:07.316
<v Speaker 2>the hope that by understanding the circuit systematically, we can

0:12:07.396 --> 0:12:13.676
<v Speaker 2>now solve so many different circuits and ultimately so many

0:12:13.676 --> 0:12:17.076
<v Speaker 2>different pathways and ultimately so many different disorders.

0:12:19.636 --> 0:12:22.956
<v Speaker 1>In a minute, Manola's describes how he and his colleagues

0:12:22.996 --> 0:12:26.476
<v Speaker 1>are trying to turn their genomic research into new medicines.

0:12:35.476 --> 0:12:36.436
<v Speaker 1>That's the end of the ads.

0:12:36.876 --> 0:12:38.036
<v Speaker 2>Now we're going back to the show.

0:12:39.036 --> 0:12:41.396
<v Speaker 1>Another area where Manola's and his colleagues have done a

0:12:41.436 --> 0:12:44.796
<v Speaker 1>lot of work is on Alzheimer's disease. They looked at

0:12:44.836 --> 0:12:48.876
<v Speaker 1>a common genetic variant called apo E four. People with

0:12:48.956 --> 0:12:51.556
<v Speaker 1>two copies of this variant have a much much higher

0:12:51.636 --> 0:12:54.956
<v Speaker 1>risk of getting Alzheimer's, and Manola's and his colleagues were

0:12:54.956 --> 0:12:57.996
<v Speaker 1>trying to figure out why. They found that having this

0:12:58.116 --> 0:13:02.436
<v Speaker 1>Apoe four variant was linked to problems with moving cholesterol

0:13:02.636 --> 0:13:07.956
<v Speaker 1>around in the brain, a process called cholesterol transport. Then

0:13:08.156 --> 0:13:11.356
<v Speaker 1>they did experiments and mice that found that drugs that

0:13:11.436 --> 0:13:17.036
<v Speaker 1>restore cholesterol transport actually restored cognition in the mice. Now

0:13:17.156 --> 0:13:21.316
<v Speaker 1>that's in mice, and Alzheimer's is a notoriously difficult disease

0:13:21.396 --> 0:13:25.316
<v Speaker 1>to treat in humans. So I asked Minolas what it

0:13:25.356 --> 0:13:28.116
<v Speaker 1>will take to move his research from mice to humans,

0:13:28.476 --> 0:13:31.956
<v Speaker 1>and his answer was really interesting. It pointed not only

0:13:31.956 --> 0:13:35.276
<v Speaker 1>two ideas about treating Alzheimer's, but to bigger ideas about

0:13:35.316 --> 0:13:37.116
<v Speaker 1>treating human disease more generally.

0:13:38.236 --> 0:13:39.916
<v Speaker 2>The way that I'm thinking about this, the way that

0:13:39.956 --> 0:13:43.116
<v Speaker 2>our team is thinking about these, is how do we

0:13:43.276 --> 0:13:49.476
<v Speaker 2>enable personalized medicine and precision medicine. Namely, Alzheimer's is not

0:13:49.476 --> 0:13:51.956
<v Speaker 2>going to be only about transport. It's going to be

0:13:51.996 --> 0:13:56.276
<v Speaker 2>a combination. Every person has some combination of these regulations.

0:13:56.716 --> 0:14:00.596
<v Speaker 2>A point four is the strongest genetic risk, but there

0:14:00.596 --> 0:14:03.676
<v Speaker 2>are many others. And the question is how do we

0:14:03.996 --> 0:14:07.476
<v Speaker 2>now systematically take a person with Alzheimer's, or take a

0:14:07.516 --> 0:14:12.036
<v Speaker 2>family with risk, develop treatments that are either directly addressing

0:14:12.036 --> 0:14:17.196
<v Speaker 2>the root causes rather than treating the symptoms, and are

0:14:17.356 --> 0:14:22.556
<v Speaker 2>not only preventative but adapted to every family and every person.

0:14:22.876 --> 0:14:25.116
<v Speaker 1>And just to be clear, like having you know, two

0:14:25.196 --> 0:14:30.196
<v Speaker 1>copies of the APO four lil is neither necessary nor

0:14:30.196 --> 0:14:32.796
<v Speaker 1>sufficient to get Alzheimer's. Right, that's exactly both of them

0:14:32.796 --> 0:14:34.436
<v Speaker 1>and not get it. You can have neither of them

0:14:34.476 --> 0:14:37.756
<v Speaker 1>and get it. So it's exactly so complicated hard.

0:14:37.836 --> 0:14:41.676
<v Speaker 2>So, as with everything with human disease, genetics is not destiny.

0:14:42.076 --> 0:14:45.836
<v Speaker 2>Genetics is a predisposition, and there are environmental factors. There

0:14:45.876 --> 0:14:50.316
<v Speaker 2>are behavioral factors, there are nutritional exercise factors, there are

0:14:50.356 --> 0:14:52.836
<v Speaker 2>socio economic factors. There's so many other factors that are

0:14:52.876 --> 0:14:58.836
<v Speaker 2>affecting how your genetics will manifest ultimately into disease. But

0:14:59.076 --> 0:15:02.316
<v Speaker 2>now the question is for every person, how do we

0:15:02.676 --> 0:15:06.636
<v Speaker 2>create a drug? And it's not going to be feasible

0:15:06.756 --> 0:15:11.276
<v Speaker 2>economically or in any other way to create one pill

0:15:11.316 --> 0:15:13.716
<v Speaker 2>for each person. The way that we're going to enable

0:15:13.716 --> 0:15:17.916
<v Speaker 2>personalized medicine is by understanding what are the hallmarks of disease,

0:15:18.316 --> 0:15:20.916
<v Speaker 2>what are the hallmarks of Alzheimer's, the wholemarks of obesity,

0:15:20.996 --> 0:15:23.916
<v Speaker 2>the whole moods of diabetes, the hallmarks of cardiac disorders,

0:15:24.276 --> 0:15:28.436
<v Speaker 2>and develop therapeutics for every one of those hallmarks. So

0:15:28.516 --> 0:15:31.836
<v Speaker 2>think of it as an arsenal of twelve or twenty

0:15:32.076 --> 0:15:35.076
<v Speaker 2>different drugs for Alzheimer's that you're going to be taking

0:15:35.076 --> 0:15:37.156
<v Speaker 2>a combination of it.

0:15:37.196 --> 0:15:41.156
<v Speaker 1>Seems like oncology is already some way down that road, right,

0:15:41.196 --> 0:15:44.876
<v Speaker 1>I mean, you know her two positive breast cancers have

0:15:44.996 --> 0:15:47.036
<v Speaker 1>certain drugs that target them that sort of thing, right,

0:15:47.116 --> 0:15:47.836
<v Speaker 1>is that the model?

0:15:48.596 --> 0:15:51.876
<v Speaker 2>That's exactly the model. So the hallmarks of cancer have

0:15:52.036 --> 0:15:55.116
<v Speaker 2>been the way of thinking about cancer for twenty plus

0:15:55.236 --> 0:15:58.716
<v Speaker 2>years now. And the difference in cancer is the following.

0:15:59.476 --> 0:16:04.356
<v Speaker 2>Cancer is subject to positive selection. What does that mean?

0:16:04.716 --> 0:16:09.236
<v Speaker 2>That means that because it's a replicative disorder where the cell,

0:16:09.356 --> 0:16:12.836
<v Speaker 2>the cancer cells make more of themselves. If a cell

0:16:12.916 --> 0:16:17.636
<v Speaker 2>acquires a mutation that allows it to replicate faster, you

0:16:17.716 --> 0:16:21.396
<v Speaker 2>will have more of that cell. So you are subject

0:16:21.476 --> 0:16:25.716
<v Speaker 2>to positive selection where the bad mutations are increasing in

0:16:25.756 --> 0:16:32.556
<v Speaker 2>frequency in every generation of the cancer. By contrast, most

0:16:32.596 --> 0:16:37.556
<v Speaker 2>complex disorders are subject to purifying selection, where the mutations

0:16:37.596 --> 0:16:40.916
<v Speaker 2>that are responsible for them are maintained at low frequency

0:16:40.916 --> 0:16:41.516
<v Speaker 2>by evolution.

0:16:42.556 --> 0:16:42.836
<v Speaker 1>Huh.

0:16:43.356 --> 0:16:47.556
<v Speaker 2>So it's working at the opposite ends of the evolutionary spectrum.

0:16:47.836 --> 0:16:50.796
<v Speaker 2>So cancer has a small number of genes that drive

0:16:50.956 --> 0:16:55.236
<v Speaker 2>the disorder. Complex traits have thousands of genes that are

0:16:55.356 --> 0:16:59.396
<v Speaker 2>maintained at low frequency or at weak effects.

0:16:59.836 --> 0:17:03.276
<v Speaker 1>Except that sounds much harder. It's harder to figure out

0:17:03.316 --> 0:17:04.116
<v Speaker 1>what's going on harder.

0:17:05.236 --> 0:17:08.076
<v Speaker 2>But the saving grace is that even though you have

0:17:08.196 --> 0:17:12.356
<v Speaker 2>extreme heterogeneity in the number of drivers, for every one

0:17:12.356 --> 0:17:19.476
<v Speaker 2>of these disorders, they coalesce, they cluster, they converge in

0:17:19.556 --> 0:17:24.276
<v Speaker 2>a small number of recurrent pathways, and these are the hallmarks.

0:17:24.676 --> 0:17:24.876
<v Speaker 1>Huh.

0:17:25.396 --> 0:17:28.716
<v Speaker 2>So you can find multiple genes associated with lipid transport,

0:17:28.996 --> 0:17:32.036
<v Speaker 2>you can find multiple genes associated with new inflammation with

0:17:32.156 --> 0:17:33.156
<v Speaker 2>DNA damage, so.

0:17:33.116 --> 0:17:35.876
<v Speaker 1>You target the sort of pathways where they converge.

0:17:35.956 --> 0:17:37.876
<v Speaker 2>That's exactly right. So we're not going to make a

0:17:38.036 --> 0:17:40.916
<v Speaker 2>drug for Alzheimer's that we might make a drug for

0:17:41.036 --> 0:17:44.716
<v Speaker 2>DNA damage, a drug for lipid metabolism, a drug for

0:17:44.796 --> 0:17:48.076
<v Speaker 2>cholesterol transport, et cetera. And that's what we're working.

0:17:48.356 --> 0:17:50.916
<v Speaker 1>That's satisfying. That's a satisfying explanation.

0:17:51.316 --> 0:17:54.876
<v Speaker 2>It basically says that it is a limited number. There's

0:17:54.916 --> 0:17:57.076
<v Speaker 2>a billion people in the planet. We're not going to

0:17:57.116 --> 0:17:59.356
<v Speaker 2>have a billion drugs. What we're going to have it's

0:17:59.396 --> 0:18:02.796
<v Speaker 2>a small number of drugs, one for each pathway, and

0:18:02.916 --> 0:18:07.276
<v Speaker 2>these are sometimes going to be actually reused between different disorders.

0:18:07.836 --> 0:18:10.796
<v Speaker 2>So we work on cardie disorders, we're finding the same

0:18:10.916 --> 0:18:16.196
<v Speaker 2>genes underlying Alzheimer's, and specifically the lipid and cholesterol component

0:18:16.676 --> 0:18:20.196
<v Speaker 2>are in fact reused in the heart disease. And again

0:18:20.236 --> 0:18:25.356
<v Speaker 2>it's about lipids. It's about saturation of the fat stores

0:18:25.396 --> 0:18:28.036
<v Speaker 2>of an individual and now the lipid escaping into the

0:18:28.036 --> 0:18:32.036
<v Speaker 2>blacks into the bloodstream, forming these plaques that will then

0:18:32.196 --> 0:18:35.756
<v Speaker 2>cause heart you know, failure and heart damage and so

0:18:35.796 --> 0:18:38.836
<v Speaker 2>and so forth. So that's where we're at.

0:18:39.036 --> 0:18:43.236
<v Speaker 1>So is there. I mean, the dream is that there

0:18:43.316 --> 0:18:46.476
<v Speaker 1>is some dysfunction that is common to all these different

0:18:46.516 --> 0:18:51.156
<v Speaker 1>diseases that you could target, right, Like, I mean, the

0:18:51.276 --> 0:18:53.956
<v Speaker 1>naive dream is find the cure for everything, or not everything,

0:18:53.996 --> 0:18:55.596
<v Speaker 1>but find the cure for a lot of things, or

0:18:55.636 --> 0:18:59.316
<v Speaker 1>at least find a drug that will reduce risks of

0:18:59.396 --> 0:19:02.916
<v Speaker 1>many different bad things, right, I mean, is that plausible

0:19:02.996 --> 0:19:05.476
<v Speaker 1>or am I just naive in going there? From what

0:19:05.516 --> 0:19:05.996
<v Speaker 1>you're saying.

0:19:06.276 --> 0:19:11.796
<v Speaker 2>So you're right that some of the time these pathways

0:19:11.796 --> 0:19:14.796
<v Speaker 2>that we're finding are going to be helping in multiple frauds,

0:19:15.636 --> 0:19:18.476
<v Speaker 2>And then that's absolutely the dream. We should basically start

0:19:18.596 --> 0:19:21.036
<v Speaker 2>not with what is the worst disease, but maybe what

0:19:21.116 --> 0:19:23.596
<v Speaker 2>is the best pathway that if we fix that one,

0:19:23.676 --> 0:19:26.156
<v Speaker 2>we're going to have an impact on most diseases.

0:19:25.956 --> 0:19:28.636
<v Speaker 1>Right, like the highest return on investments for example.

0:19:28.676 --> 0:19:30.556
<v Speaker 2>Like, Yeah, that's a great way to think about it.

0:19:31.956 --> 0:19:35.276
<v Speaker 2>But the way that I would say is that for

0:19:35.636 --> 0:19:38.236
<v Speaker 2>each person, this might be a different molecule.

0:19:39.876 --> 0:19:42.396
<v Speaker 1>So now I'm not hopeful.

0:19:43.596 --> 0:19:47.036
<v Speaker 2>But that with a small number of these molecules, say

0:19:47.076 --> 0:19:48.956
<v Speaker 2>one hundred, one hundred and fifty two hundred molecules.

0:19:48.956 --> 0:19:50.436
<v Speaker 1>When you say molecule, you mean drug.

0:19:50.356 --> 0:19:52.836
<v Speaker 2>I mean trust, might I mean drust. Yeah, Basically that

0:19:52.876 --> 0:19:54.956
<v Speaker 2>there's going to be a small number of pathways and

0:19:55.036 --> 0:19:59.396
<v Speaker 2>a small number of these modulators, and that those are

0:19:59.396 --> 0:20:01.876
<v Speaker 2>going to be mixed and matched in each person to

0:20:02.116 --> 0:20:04.996
<v Speaker 2>then target a communatorially large number of people.

0:20:05.076 --> 0:20:07.556
<v Speaker 1>Yeah, it just got hard. I know, I know biology

0:20:07.676 --> 0:20:10.196
<v Speaker 1>is hard, but I got up to for a second.

0:20:10.836 --> 0:20:12.596
<v Speaker 2>There's not going to be a single silver bullet for

0:20:13.076 --> 0:20:15.276
<v Speaker 2>all of those. In fact, for any one of these diseases,

0:20:15.276 --> 0:20:17.996
<v Speaker 2>there's no silver bullet. But the moment you build your

0:20:18.076 --> 0:20:20.956
<v Speaker 2>panelbly of fifty silver bullets, then you're going to be

0:20:20.996 --> 0:20:24.196
<v Speaker 2>hitting two hundred diseases. That's the beauty of it.

0:20:24.396 --> 0:20:26.996
<v Speaker 1>Fifty bronze bo there's no silver bullet, but maybe.

0:20:26.836 --> 0:20:28.236
<v Speaker 2>You can find it for hearts exactly right.

0:20:30.356 --> 0:20:43.916
<v Speaker 1>We'll be back in a minute with the lightning round. Now,

0:20:43.956 --> 0:20:46.516
<v Speaker 1>let's get back to the show. I read that you

0:20:46.676 --> 0:20:48.876
<v Speaker 1>have been an author on more than two hundred and

0:20:48.956 --> 0:20:52.156
<v Speaker 1>thirty papers, which is a lot. Which one was the

0:20:52.156 --> 0:20:52.636
<v Speaker 1>most fun?

0:20:52.756 --> 0:20:54.196
<v Speaker 2>Oh? You know what, don't I tell you about my

0:20:54.316 --> 0:20:54.876
<v Speaker 2>very first one?

0:20:54.916 --> 0:20:55.196
<v Speaker 1>Sure?

0:20:56.756 --> 0:20:59.876
<v Speaker 2>And the very first paper was published in c graph

0:21:00.036 --> 0:21:02.196
<v Speaker 2>and it now has like two thousand citations, And it

0:21:02.236 --> 0:21:05.916
<v Speaker 2>was about how do we reconstruct the surface of an

0:21:05.956 --> 0:21:09.836
<v Speaker 2>object from a cloud of points? So you can basically

0:21:09.916 --> 0:21:12.476
<v Speaker 2>use laser scanning to sort of figure out points in

0:21:12.516 --> 0:21:14.636
<v Speaker 2>three D and then the question is what is the

0:21:14.676 --> 0:21:17.516
<v Speaker 2>surface that goes between them. I've always been fascinated with

0:21:17.556 --> 0:21:19.716
<v Speaker 2>three D space, so it was very fun for me

0:21:19.796 --> 0:21:22.036
<v Speaker 2>to just like you know, as a kid, basically as

0:21:22.116 --> 0:21:25.636
<v Speaker 2>as a freshman at to work on such a project

0:21:25.716 --> 0:21:28.916
<v Speaker 2>and then showing up at the conference. He was in Disneyland,

0:21:29.196 --> 0:21:30.876
<v Speaker 2>so it was my first time in Disneyland as an

0:21:30.916 --> 0:21:31.996
<v Speaker 2>author of a vapor.

0:21:31.836 --> 0:21:35.156
<v Speaker 1>Sounds relevant for motion capture, not knowing anything about it.

0:21:35.196 --> 0:21:38.636
<v Speaker 1>When I think of, like, you know, people, the way

0:21:38.636 --> 0:21:40.636
<v Speaker 1>they make movies now exactly as they put a bunch

0:21:40.676 --> 0:21:42.876
<v Speaker 1>of censors on people and they move around and then

0:21:42.916 --> 0:21:45.276
<v Speaker 1>you can turn them into a dragon or whatever you want.

0:21:45.316 --> 0:21:48.636
<v Speaker 2>Yeah, that's exactly right. So you know that paper has

0:21:48.676 --> 0:21:50.756
<v Speaker 2>been quite influential and used for a lot of a

0:21:50.796 --> 0:21:51.676
<v Speaker 2>lot of different things.

0:21:52.076 --> 0:21:54.276
<v Speaker 1>What's the most overrated Greek island?

0:21:54.316 --> 0:21:55.756
<v Speaker 2>Oh my god, I can tell you about the most

0:21:55.836 --> 0:21:59.676
<v Speaker 2>underrated Santorini. Definitely not overrated tons of people, but worth

0:21:59.836 --> 0:22:02.276
<v Speaker 2>every time. I can tell you about my first day

0:22:02.316 --> 0:22:05.516
<v Speaker 2>in Santorini, which is I walked out on this balcony

0:22:05.796 --> 0:22:07.716
<v Speaker 2>and I asked the owner of the restaurant if I

0:22:07.756 --> 0:22:09.036
<v Speaker 2>can take a look at the view and I'm not

0:22:09.436 --> 0:22:12.996
<v Speaker 2>order anything. He said, please be my guest, and I

0:22:13.036 --> 0:22:15.196
<v Speaker 2>walked out, and ten minutes later, I'm like, I can't leave.

0:22:15.236 --> 0:22:18.556
<v Speaker 2>I'm gonna have to order. He tells me, ten years ago,

0:22:18.596 --> 0:22:19.836
<v Speaker 2>I came here to look at the view.

0:22:19.916 --> 0:22:21.756
<v Speaker 1>I want you to throw a little bit of shade.

0:22:21.836 --> 0:22:23.556
<v Speaker 1>I want you to get in a little bit of drug.

0:22:23.596 --> 0:22:23.996
<v Speaker 2>Can't.

0:22:24.116 --> 0:22:26.636
<v Speaker 1>What's one place in Greece I should not cannot.

0:22:28.356 --> 0:22:32.676
<v Speaker 2>It's not possible. I mean, you know, if you keep insisting,

0:22:32.676 --> 0:22:34.836
<v Speaker 2>I'll give you another twenty amazing places to visit.

0:22:35.236 --> 0:22:38.116
<v Speaker 1>Well, that's fair, that's fair. I did what I could do.

0:22:38.596 --> 0:22:41.396
<v Speaker 1>If everything goes well, what problem will you be trying

0:22:41.396 --> 0:22:43.036
<v Speaker 1>to solve in five years?

0:22:43.676 --> 0:22:46.836
<v Speaker 2>I think what I'm trying to solve now of actually

0:22:47.756 --> 0:22:53.156
<v Speaker 2>creating these drugs in such a modular, AI driven, personalized,

0:22:53.796 --> 0:22:58.076
<v Speaker 2>reusable way, centered on pathways. That's going to keep me

0:22:58.116 --> 0:23:01.076
<v Speaker 2>busy for a long time. And I hope that in

0:23:01.116 --> 0:23:05.876
<v Speaker 2>five years we have actually sold a big chunk of

0:23:05.916 --> 0:23:10.036
<v Speaker 2>the platform and that we have a few drugs in

0:23:10.076 --> 0:23:13.076
<v Speaker 2>clinical trials. So you know, my dream needs to take

0:23:13.116 --> 0:23:16.196
<v Speaker 2>all of these circuits that we have uncovered and make

0:23:16.236 --> 0:23:18.316
<v Speaker 2>a difference for humanity, make a difference for you know,

0:23:18.356 --> 0:23:21.116
<v Speaker 2>my fellow beings. That's my big goal.

0:23:21.596 --> 0:23:23.596
<v Speaker 1>Great, it's fun to talk to you.

0:23:23.996 --> 0:23:26.516
<v Speaker 2>I learned a lot, such a pleasure, thank you, and

0:23:26.556 --> 0:23:29.516
<v Speaker 2>I love that you're fearless. You're like, well, we're gonna

0:23:29.596 --> 0:23:32.596
<v Speaker 2>jump into this new topic and find it all about it.

0:23:36.356 --> 0:23:39.676
<v Speaker 1>Man nola's Kellis is a professor of computer science at MIT.

0:23:40.716 --> 0:23:45.036
<v Speaker 1>Today's show was produced by Edith Russelo, edited by Karen Chakerji,

0:23:45.396 --> 0:23:48.796
<v Speaker 1>and engineered by Sarah Bruguer. You can email us at

0:23:48.916 --> 0:23:53.196
<v Speaker 1>problem at pushkin dot FM. I'm Jacob Goldstein. One last

0:23:53.236 --> 0:23:55.316
<v Speaker 1>thing we are going to be taking a break for

0:23:55.396 --> 0:23:57.436
<v Speaker 1>a couple of weeks, but we'll be back with new

0:23:57.476 --> 0:24:01.436
<v Speaker 1>shows in early twenty twenty four. Thanks for listening, Happy

0:24:01.436 --> 0:24:10.436
<v Speaker 1>New Year, that t